Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-19 Purchase |
2023-09-19 9:47 pm |
Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO |
15,000 | $12.62 | $189,371 | 524,793 (Indirect Direct) |
View |
| 2023-05-09 Purchase |
2023-05-11 9:06 pm |
ACELYRIN Inc. | SLRN | Gosebruch Henry O Director |
50,000 | $18 | $900,000 | 205,450 (Direct) |
View |
| 2022-05-16 Sale(A) |
2022-05-20 5:03 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $155 | $13,013,800 | 98,761 (Indirect Direct) |
View |
| 2022-03-01 Sale(A) |
2022-05-20 5:00 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
25,000 | $147.29 | $3,682,189 | 98,580 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 5:12 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $155 | $13,013,800 | 98,580 (Indirect Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 5:03 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
25,000 | $147.29 | $3,682,189 | 98,580 (Indirect Direct) |
View |
| 2022-03-01 Sale |
2022-03-01 6:14 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
15,000 | $148.26 | $2,223,836 | 123,580 (Indirect Direct) |
View |
| 2020-11-20 Sale |
2020-11-24 5:34 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
40,000 | $99.38 | $3,975,046 | 71,370 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-07 Option Award |
2024-06-11 7:11 pm |
N/A 2034-06-06 |
ACELYRIN Inc. | SLRN | Gosebruch Henry O Director |
92,158 | $0 | 92,158 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:15 pm |
N/A 2034-02-13 |
Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO |
240,000 | $0 | 764,793 (Direct) |
View |
Ownership |
2023-09-14 6:58 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO |
0 | $0 | 2,548,970 (Direct) |
View |
| 2023-05-09 Other |
2023-05-11 9:06 pm |
N/A 2033-03-22 |
ACELYRIN Inc. | SLRN | Gosebruch Henry O Director |
310,900 | $0 | 205,450 (Direct) |
View |
Ownership |
2023-05-04 7:46 pm |
N/A 2033-03-22 |
ACELYRIN Inc. | SLRN | Gosebruch Henry O Director |
0 | $0 | 155,450 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 4:31 pm |
N/A 2032-05-25 |
Aptinyx Inc. | APTX | Gosebruch Henry O Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-05-16 Exercise(A) |
2022-05-20 5:03 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $54.86 | 98,761 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 5:12 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $54.86 | 98,580 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 6:14 pm |
N/A N/A |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
30,156 | $149.54 | 123,580 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:39 pm |
2023-02-17 2032-02-16 |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
98,715 | $0 | 199,383 (Direct) |
View |
| 2021-09-07 Gift |
2021-09-10 5:01 pm |
N/A N/A |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
30,000 | $0 | 100,500 (Direct) |
View |
| 2021-05-27 Option Award |
2021-06-01 4:36 pm |
N/A 2031-05-26 |
Aptinyx Inc. | APTX | Gosebruch Henry O Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 8:34 pm |
N/A N/A |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
22,833 | $107.74 | 100,355 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 6:25 pm |
2022-02-18 2031-02-17 |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
100,606 | $0 | 171,976 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:31 pm |
N/A 2030-12-30 |
Aptinyx Inc. | APTX | Gosebruch Henry O Director |
5,339 | $2.224 | 5,339 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 3:05 pm |
N/A 2030-09-29 |
Aptinyx Inc. | APTX | Gosebruch Henry O Director |
5,490 | $2.163 | 5,490 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:06 pm |
N/A 2030-06-29 |
Aptinyx Inc. | APTX | Gosebruch Henry O Director |
4,051 | $2.677 | 4,051 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:11 pm |
N/A 2030-05-19 |
Aptinyx Inc. | APTX | Gosebruch Henry O Director |
40,000 | $0 | 40,000 (Direct) |
View |